Chia Yvonne Cashinn, Anjum Clarice Evey, Yee Hui Rong, Kenisi Yenny, Chan Mike K S, Wong Michelle B F, Pan Shing Yi
Baden R&D Laboratories GmbH, Germany.
Baden Research and Testing (Asia Pac) Sdn Bhd, Malaysia.
Stem Cells Int. 2020 Sep 4;2020:8889061. doi: 10.1155/2020/8889061. eCollection 2020.
Blood-brain barrier (BBB) is a term describing the highly selective barrier formed by the endothelial cells (ECs) of the central nervous system (CNS) homeostasis by restricting movement across the BBB. An intact BBB is critical for normal brain functions as it maintains brain homeostasis, modulates immune cell transport, and provides protection against pathogens and other foreign substances. However, it also prevents drugs from entering the CNS to treat neurodegenerative diseases. Stem cells, on the other hand, have been reported to bypass the BBB and successfully home to their target in the brain and initiate repair, making them a promising approach in cellular therapy, especially those related to neurodegenerative disease. This review article discusses the mechanism behind the successful homing of stem cells to the brain, their potential role as a drug delivery vehicle, and their applications in neurodegenerative diseases.
血脑屏障(BBB)是一个术语,用于描述由中枢神经系统(CNS)的内皮细胞(ECs)形成的高度选择性屏障,它通过限制跨血脑屏障的移动来维持中枢神经系统的内稳态。完整的血脑屏障对于正常脑功能至关重要,因为它维持脑内稳态、调节免疫细胞运输,并提供针对病原体和其他外来物质的保护。然而,它也会阻止药物进入中枢神经系统以治疗神经退行性疾病。另一方面,据报道干细胞能够绕过血脑屏障并成功归巢至脑内的靶标并启动修复,使其成为细胞治疗中一种有前景的方法,尤其是与神经退行性疾病相关的治疗。本文综述讨论了干细胞成功归巢至脑内的机制、它们作为药物递送载体的潜在作用以及它们在神经退行性疾病中的应用。